Monday, September 15, 2014
|
6:30 – 8:30 PM |
Speaker’s Dinner, Invitation only |
|
Tuesday, September 16, 2014
|
8:45 AM |
Welcome Remarks |
9:00 – 10:10 AM |
East Asia: Assessing the Opportunities & Risks in the Major Healthcare Markets
Moderator:
- Glen Giovannetti, Global Biotechnology Leader, EY
Panelists:
- May-Kin Ho, PhD,Advisory Director, Goldman Sachs & Co.
- W. Vincent Xiang, PhD. MBA, Managing Director, Vice President, International Investments and Business Development, Humanwell Healthcare Group
- Harold R. Werner, Co-Founder, HealthCare Ventures
|
10:15– 11:10 AM |
Comparing Regulatory Regimes: Understanding the Differences, Avoiding Missteps and Getting Your Drug Through the Process
Moderator:
- Scott Siegel PhD, Founder, Milestone Life Sciences, LLC
Panelists:
- John C. Balzano, JD, Special Counsel, Covington & Burling LLP
- Jurij Petrin, MD, President & CEO, Pharmaceutical Regulatory Services, Inc.
- Mark Tang, PhD, MBA, Founder and Chairman, GCA Therapeutics, Ltd.
|
11:15 – 12:10 PM |
Conducting Clinical Trials in East Asia: The Benefits and Operational Realities You Need to Know
Panelists:
- Pey Ni Chan, Managing Director, CMIC Asia-Pacific, Pte. Ltd.
- Keiko Oishi, Senior Managing Director, CMIC Co., Ltd.
- Peony Yu, MD, Vice President, Clinical Development, FibroGen, Inc.
|
12:15 – 1:40 PM |
Lunch with the Experts
Fireside Chat: Minimizing Risk to Maximize Opportunity
- Joshua Berlin, Executive Director & Editor of New Ventures, BioCentury Publications Inc.
- Alan Seem, JD, Partner, Sherman & Sterling
|
1:45 – 2:40 PM |
A Focus on China: Big Opportunities, Big Challenges and Navigating Your Way Moderator:
- Charles Hsu, PhD, Managing Partner, Crosswave Management & Senior Advisor, Mustang Ventures
Panelists:
- John Gill, Founder and Former CEO, Tetralogic Pharmaceuticals
- Andrew Pecora, MD, Chairman, TetraLogic Pharmaceuticals Corporation and Chief Visionary Officer, NeoStem, Inc.
- Joseph Vacca, PhD, Senior Vice President, Early Success Sharing Partnerships, WuXi AppTec
- Alan Yan, Co-Founder, President & CEO, Beijing SynerCare Pharma Tech Co., Ltd.
- Debra Yu, MD, Managing Director, Labrador Advisors
|
2:45 – 3:40 PM |
East Asian Biotech Venture Funds: What Are They Investing in and Where?
Moderator:
- Kimberly Ha, Senior Director, FTI Consulting
Panelists:
- Les Funtleyder, Director of Strategic Investments, OPKO Health
- Wei Li, PhD, Executive Partner-China, Fidelity Biosciences
- Anjiang (Vincent) Liu, Managing Director, International Investment & Chief Representative, NY Office, FosunPharma Group
- Tomomi Okamoto, Partner, Sophia Hill Venture Partners
- Anthony (Tony) Sun, MD, Partner, Aisling Capital
|
3:45 – 5:00 PM |
Biopharmaceutical Innovation in East Asia: What are the Drivers and Impact and Where is it Going?
Moderator:
- Joshua Berlin, Executive Director & Editor of New Ventures, BioCentury Publications Inc.
Panelists:
- Ben Bonifant, Founder & Partner, Triangle Insights Group
- Peter B. Corr, Co-Founder & Managing General Partner, Auven Therapeutics
- James Huang, Managing Partner, Kleiner Perkins Caufield & Byers China
- Kiyoshi Kurokawa, Professor, National Graduate Institute for Policy Studies & Science Advisor, National Diet, Japan
|
5:00 – 6:30 PM |
Networking Reception |
Wednesday, September 17, 2014
|
8:45 – 9:55 AM |
Expanding into East Asia: Considerations for All Management Teams
Moderator:
- Wei Zhang, PhD, Head, Corporate Development, GoodStart Genetics, Inc.
Panelists:
- Helen Chen, Head, China Life Sciences
- Martyn D. Greenacre, MBA, Former Chairman, BMP Sunstone
- Alex Waldron, Vice President Global Commercial Operations, EPIRUS Biopharmaceuticals, Inc.
- Gunther Winkler, PhD, Founder & CEO, BioMetheus LLC
- Cissy S. Young, Ph.D. MBA, Executive Director, Life Sciences Practice, Russell Reynolds Associates
|
|
10:00 11:10 AM |
Getting the Deal Done: The Due Diligence of Deal Making in Asia Moderator:
- Jack M. Anthony, Founder, BioMentorz
Panelists:
- Jay N. Fastow, JD, Partner, Ballard Spahr
- James Foley, Managing Director, Aqua Partners
- Martina Molsbergen, CEO, C14 Consulting Group
- Richard L. Sherman, JD, Senior Vice President, Strategic Transactions & General Counsel, Tetralogic Pharmaceuticals
- Wenyong Wang, PhD, Managing Director, Merchant & Investment Banking, Burrill Securities
|
|
11:15 –12:10 PM |
Intellectual Property From the Trenches: Exploiting Your Discoveries and Protecting Them at the Same Time
Moderator:
- Grace L. Pan, Partner, Orrick, Herrington & Sutcliffe LLP
Panelists:
- Ed Haug, Partner, Frommer Lawrence & Haug LLP
- Dr. Judy Jarecki-Black, Esq., Global Head, Intellectual Property, Merial Limited
- Loretta Smith, Senior IP Counsel, DuPont Legal
|
|
12:15 – 1:25 PM |
Lunch with the Experts |
|
1:30 – 2:25 PM |
South Korea: A Rising Player in the Global Biopharmaceutical Industry
Moderator:
- Do-Hyun Cho, PhD, President & CEO, W Medical Strategies
Panelists:
- Han S. Bang, Managing Director, Betachem, inc.
- Tae-Wan Kim, PhD, Associate Professor, Columbia University Medical School
|
|
2:30 – 3:45 PM |
A Big Pharma View of Global Collaboration and Trans-Pacific Drug Development
Moderator:
- Andrew Forman, Global Life Sciences, Transaction Advisory Services, EY
Panelists:
- Yuan-Hua Ding, PhD, Executive Director & Head of External R&D Innovation – Asia/Pacific, Pfizer
- Iain D. Dukes, MA, D.Phil, Senior Vice President, MRL Licensing and External Scientific Affairs, Merck
- Terence G. Porter, PhD, Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals International, Inc.
- Theodore Torphy, PhD, Senior Vice President, Research & Development, BioMotiv
|
|
3:45 – 4:45 PM |
Closing Reception |
|